Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
- PMID: 26869413
- DOI: 10.1016/j.xphs.2015.11.040
Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
Abstract
Transport proteins in intestinal epithelial cells facilitate absorption of nutrients/compounds that are organic anions, cations, and zwitterions. For two decades, we have studied intestinal absorption and transport of hydrophilic ionic compounds, with specific focus on transport properties of organic cations and their interactions with intestinal transporters and tight junction proteins. Our data reveal how complex interactions between a compound and transporters in intestinal apical/basolateral (BL) membranes and tight junction proteins define oral absorption, and that the BL membrane lacks an efflux transporter that can transport positively charged compounds. Based on our investigations of transport mechanisms of zwitterionic, anionic, and cationic compounds, we postulate that physicochemical properties of these ionic species, in relation to the intestinal micro pH environment, have exerted evolutionary pressure for development of transporters that can handle apical uptake/efflux of all 3 ionic species and BL efflux of anions and zwitterions, but such evolutionary pressure is lacking for development of a BL efflux transporter for cationic compounds. This review provides an overview of intestinal uptake/efflux transporters and describes our studies on intestinal transport of cationic, anionic, and zwitterionic drugs that led to hypothesize that there are no cation-selective BL efflux transporters in the intestine.
Keywords: drug transport; intestinal absorption; intestinal epithelia; metformin; organic cation transporter; transporters.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.Mol Pharm. 2021 Jun 7;18(6):2198-2207. doi: 10.1021/acs.molpharmaceut.0c01104. Epub 2021 May 6. Mol Pharm. 2021. PMID: 33956455
-
Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.Pharm Res. 2006 Jun;23(6):1165-77. doi: 10.1007/s11095-006-0251-4. Epub 2006 Jun 8. Pharm Res. 2006. PMID: 16741655
-
Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.Mol Pharm. 2011 Oct 3;8(5):1677-86. doi: 10.1021/mp200026v. Epub 2011 Aug 5. Mol Pharm. 2011. PMID: 21780830
-
SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties.Curr Top Membr. 2014;73:233-61. doi: 10.1016/B978-0-12-800223-0.00006-2. Curr Top Membr. 2014. PMID: 24745985 Review.
-
Targeting intestinal transporters for optimizing oral drug absorption.Curr Drug Metab. 2010 Nov;11(9):730-42. doi: 10.2174/138920010794328850. Curr Drug Metab. 2010. PMID: 21189135 Review.
Cited by
-
Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?Front Pharmacol. 2021 Apr 14;12:648388. doi: 10.3389/fphar.2021.648388. eCollection 2021. Front Pharmacol. 2021. PMID: 33935750 Free PMC article. Review.
-
Ianus Bifrons: The Two Faces of Metformin.Cancers (Basel). 2024 Mar 26;16(7):1287. doi: 10.3390/cancers16071287. Cancers (Basel). 2024. PMID: 38610965 Free PMC article. Review.
-
Enhanced Intestinal Permeability and Plasma Concentration of Metformin in Rats by the Repeated Administration of Red Ginseng Extract.Pharmaceutics. 2019 Apr 18;11(4):189. doi: 10.3390/pharmaceutics11040189. Pharmaceutics. 2019. PMID: 31003498 Free PMC article.
-
Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues.PLoS One. 2021 Apr 7;16(4):e0249594. doi: 10.1371/journal.pone.0249594. eCollection 2021. PLoS One. 2021. PMID: 33826656 Free PMC article. Clinical Trial.
-
Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery.J Pharmacol Exp Ther. 2023 Dec;387(3):328-336. doi: 10.1124/jpet.123.001828. Epub 2023 Sep 28. J Pharmacol Exp Ther. 2023. PMID: 37770201 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources